Trade Pfizer ^PFE

Jain Global LLC Boosts Stake in Pfizer Inc. $PFE

Focus Partners Wealth Acquires 551,274 Shares of Pfizer Inc. $PFE

CT cannot afford to delay the Southeast Resiliency Project

Pfizer Inc. $PFE Shares Bought by Gotham Asset Management LLC - Markets Daily

Does Apellis Pharmaceuticals' (APLS) New Board Member Reveal a Deeper R&D Commercialization Strategy Shift? - Simply Wall St News

First Western Trust Bank Has $569,000 Position in Pfizer Inc. $PFE - Markets Daily

Gotham Asset Management LLC Grows Position in Pfizer Inc. $PFE

Destination Wealth Management Has $21.92 Million Position in Pfizer Inc. $PFE - Markets Daily

Ameriprise Financial Inc. Increases Holdings in Pfizer Inc. $PFE

Pfizer Inc. $PFE Stake Reduced by First Western Trust Bank - Stock Observer

Is Pfizer Inc. (PFE) A Good Stock To Buy Now?

Empiric azithromycin alters the upper respiratory microbiome and resistome without anti-inflammatory benefit in COVID-19

Is Pfizer Inc. (PFE) One of Goldman Sachs Top Healthcare Stocks?

Pfizer Pipeline Updates Test Valuation Gap As New Trials Begin

Pfizer Inc. $PFE Shares Sold by CSM Advisors LLC

Community Bank N.A. Has $1.60 Million Holdings in Pfizer Inc. $PFE - Stock Observer

Capitolis Liquid Global Markets LLC Purchases 1,351,000 Shares of Pfizer Inc. $PFE - Daily Political

Pfizer Inc. $PFE Shares Acquired by California Public Employees Retirement System - Daily Political

Pfizer (PFE) and Iron Mountain (IRM) lead the Bull Strangle watch list for this week

Goldman Sachs Healthcare Stocks: Top 10 Stock Picks

China Obesity Approval Puts Pfizer's GLP 1 Bet In Sharper Focus

Top Pharmaceutical Stocks To Watch Today - March 14th - Stock Observer

Ossiam Sells 4,709,790 Shares of Pfizer Inc. $PFE

Pfizer Inc. $PFE Shares Sold by Marathon Capital Management

Integral Health Asset Management LLC Trims Holdings in Pfizer Inc. $PFE - Stock Observer

Fairfax Financial Holdings Ltd. Can Buys 240,000 Shares of Pfizer Inc. $PFE - Stock Observer

Comerica Bank Sells 48,571 Shares of Pfizer Inc. $PFE - Stock Observer

Symbol: ZPFE Security name: Pfizer (PFE) BMO CDR (CAD Hedge

Eliquis Outperforms Xarelto in Safety for Treating Deep Blood Clots, ETPharma

Nektar Therapeutics (NASDAQ:NKTR) Q4 2025 Earnings Call Transcript

AI in Life Sciences Market, 2026-2040 Industry Trends and Global Forecasts - IBM, IQVIA and Oracle Lead Data Platforms While Roche, Pfizer and AI Startups Accelerate Drug Discovery Innovation

SeaCrest Wealth Management LLC Has $1.66 Million Stake in Pfizer Inc. $PFE - Daily Political

Martingale Asset Management L P Has $12.88 Million Stock Holdings in Pfizer Inc. $PFE - Daily Political

PENBRAYA (Pfizer) Market Research Report 2026: Epidemiology, Pipeline Analysis, Trends, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F | Valuespectrum.com

Building a gene editing lexicon: a model for rare and inherited disorders

Pfizer (NYSE:PFE) Shares Down 1.7% - Here's Why

Rep. Gilbert Ray Cisneros, Jr. Buys Shares of Pfizer Inc. (NYSE:PFE) - Daily Political

BridgeBio Pharma CEO Teases Pipeline Launches, Attruby Momentum, and Pfizer Tafamidis Trial Update - Daily Political

Dividend-paying pharma stock looks poised for a comeback, charts show

Merck's WELIREG Kidney Cancer Trials Deepen Oncology Growth Story

Promising Pharmaceutical Stocks To Watch Now - March 12th - Stock Observer

Radioligand Therapies Market Set for Significant Growth by 2034, Driven by Rising Cancer Burden and Targeted Radiopharmaceutical Innovation | DelveInsight

How Investors Are Reacting To Pfizer (PFE) Phase 2 Win For Tilrekimig In Atopic Dermatitis

Pfizer Inc. $PFE Shares Sold by SevenBridge Financial Group LLC - Markets Daily

The Best Covered Call Strategy to Trade High-Yielding Pfizer Stock and Earn Extra Income

Mackenzie Financial Corp Raises Holdings in Pfizer Inc. $PFE

How Tilrekimig's Trispecific Eczema Data At Pfizer (PFE) Has Changed Its Investment Story

Pfizer's Weight Management Drug Wins China Approval

Franklin Resources Inc. Raises Stock Holdings in Pfizer Inc. $PFE - Daily Political

Pfizer, Teva lose bid to disqualify ex-prosecutor in generic drug price‑fixing case

ctDNA and tumor-based biomarkers of giredestrant response in acelERA breast cancer

Seroprevalence of anti-AAV antibodies in a healthy adult Spanish population: findings from the SAAVIA study

651,996 Shares in Pfizer Inc. $PFE Bought by Kepler Cheuvreux Suisse SA

MNCs, Indian drugmakers diverge to mutual gain: How win-win is it? - Rediff.com

Richard Bernstein Advisors LLC Sells 65,636 Shares of Pfizer Inc. $PFE - Daily Political

Pfizer Tariff Exemptions And US$70b Pledge Reshape Valuation Debate

BioNTech Founders to Leave Company by 2026 for New mRNA Venture, ETPharma

B cell imprinting in children impairs antibodies to the haemagglutinin stalk

Does Olema Pharmaceuticals (OLMA) Still Stand Apart After Roche's Breast Cancer Trial Setback?

Pfizer (NYSE:PFE) Trading 1.2% Higher - Time to Buy?

Pfizer (NYSE:PFE) Trading 1.2% Higher - What's Next? - Daily Political

Pfizer Inc. $PFE Shares Bought by Causeway Capital Management LLC

Neumega (Pfizer, (Wyeth Pharmaceuticals)) Market Research Report 2026: Epidemiology, Pipeline Analysis, Market Insights & Forecasts, 2020-2025, 2025-2030F, 2035F

Natixis Advisors LLC Has $44.06 Million Stock Holdings in Pfizer Inc. $PFE - Markets Daily

Comirnaty (Pfizer, BioNTech: Tozinameran) Market Research Report 2026: Epidemiology, Pipeline Analysis, Market Insights & Forecasts, 2020-2025, 2025-2030F, 2035F

Health experts discuss new biosimilar treatments for patients in Việt Nam

Banque Cantonale Vaudoise Sells 92,252 Shares of Pfizer Inc. $PFE

Legal & General Group Plc Purchases 3,296,415 Shares of Pfizer Inc. $PFE - Stock Observer

Van ECK Associates Corp Sells 4,744,499 Shares of Pfizer Inc. $PFE - Daily Political

Natixis Advisors LLC Sells 522,523 Shares of Pfizer Inc. $PFE - Stock Observer

GIPR antagonists reported in Pfizer patent | BioWorld

Artifacts worth millions sold illegally in Nanjing Museum scandal

Diagnostic uncertainty of clinical T2 disease and its impact on treatment stratification in upper tract urothelial carcinoma: a multicenter retrospective study

Pfizer (PFE) Valuation Check After New Tilrekimig Phase 2 Success And Pipeline Progress

Neuroendocrine Carcinoma Market Poised for Significant Growth During the Forecast Period (2026-2036) Driven by Rising Incidence and Advancements in Targeted Therapies | DelveInsight

Factbox-Global drugmakers rush to boost US presence as tariff threat looms

Trumenba (Pfizer) Market Research Report 2026: Epidemiology, Pipeline Analysis, Market Insights & Forecasts, 2020-2025, 2025-2030F, 2035F

Abrysvo or Arexvy Market Research Report 2026: Epidemiology, Pipeline Analysis, Leading Companies, Market Insights & Forecasts, 2020-2025, 2025-2030F, 2035F

Pfizer's Tilrekimig Successfully Reduces Eczema Symptoms in Mid-Stage Trial, ETPharma

Prevnar Market Research Report 2026: Epidemiology, Pipeline Analysis, Market Insights & Forecasts, 2020-2025, 2025-2030F, 2035F

Swiss National Bank Trims Stake in Pfizer Inc. $PFE

Schroder Investment Management Group Sells 203,688 Shares of Pfizer Inc. $PFE - Markets Daily

562,908 Shares in Pfizer Inc. $PFE Bought by WINTON GROUP Ltd

Pfizer: Tilrekimig Antibody Phase 2 Study Meets Primary Goal In Moderate To Severe Atopic Dermatitis

Pfizer's eczema drug meets main goal in mid-stage trial, plans late-stage study

LGT Group Foundation Buys 423,419 Shares of Pfizer Inc. $PFE

Roche Stock Plummets as Giredestrant Fails Breast Cancer Trial, ETPharma

Pfizer's Phase 2 Study of Trispecific Antibody Positive in Moderate to Severe Atopic Dermatitis

Roche shares dip as oral breast cancer drug fails trial